Frequency of metabolic syndrome in schizophrenic patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
DOI: | 10.33448/rsd-v10i11.18904 |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/18904 |
Resumo: | Introduction: Metabolic Syndrome (MS) is characterized by a set of factors that increase the risk of cardiovascular diseases related to central obesity and insulin resistance. The numbers of morbidity and mortality and socioeconomic costs to public health services are alarming and their prevalence varies according to the diagnostic criteria and the population studied. The world population has a prevalence of 25%, considering schizophrenic patients, the mean MS prevalence rate found is 32.5%. Schizophrenia is a chronic psychosis without a defined cause, a multifactorial disease that appears slowly or suddenly and is related to health problems, such as difficulty with self-care, thought processing, interpersonal relationships, which favors social isolation and difficulty in the rehabilitation process. Objectives: To determine the prevalence of metabolic syndrome (MS) in schizophrenic patients according to the international diagnostic criteria of NCEP / ATP / III and IDF. Methods: Cross-sectional and analytical epidemiological study. Socioeconomic, anthropometric, clinical and biochemical data were collected. For data analysis, absolute, relative and multivariate frequency measures were used, and a significance level of 5% was considered. Results: The frequency of MS was 38.9 and 43.1%, NCEP / ATP / III and IDF respectively. Women had a greater presence of MS and altered waist circumference than men. The group with MS changed more frequently in terms of individual components changed compared to the group without MS. Conclusion: The frequency of MS and its individual components altered was high, especially among women. |
id |
UNIFEI_9275a853b60b5fac77a095e7ea36f0b2 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/18904 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
spelling |
Frequency of metabolic syndrome in schizophrenic patients Frecuencia de síndrome metabólico en pacientes esquizofrénicos Frequência da síndrome metabólica em pacientes esquizofrênicosMetabolyc SyndromeHeart Disease Risk FactorsSchizophrenia.Síndrome MetabólicoFactores de Riesgo de Enfermedad CardiacaEsquizofrenia.Síndrome MetabólicaFatores de Risco para Doenças CardiovascularesEsquizofrenia.Introduction: Metabolic Syndrome (MS) is characterized by a set of factors that increase the risk of cardiovascular diseases related to central obesity and insulin resistance. The numbers of morbidity and mortality and socioeconomic costs to public health services are alarming and their prevalence varies according to the diagnostic criteria and the population studied. The world population has a prevalence of 25%, considering schizophrenic patients, the mean MS prevalence rate found is 32.5%. Schizophrenia is a chronic psychosis without a defined cause, a multifactorial disease that appears slowly or suddenly and is related to health problems, such as difficulty with self-care, thought processing, interpersonal relationships, which favors social isolation and difficulty in the rehabilitation process. Objectives: To determine the prevalence of metabolic syndrome (MS) in schizophrenic patients according to the international diagnostic criteria of NCEP / ATP / III and IDF. Methods: Cross-sectional and analytical epidemiological study. Socioeconomic, anthropometric, clinical and biochemical data were collected. For data analysis, absolute, relative and multivariate frequency measures were used, and a significance level of 5% was considered. Results: The frequency of MS was 38.9 and 43.1%, NCEP / ATP / III and IDF respectively. Women had a greater presence of MS and altered waist circumference than men. The group with MS changed more frequently in terms of individual components changed compared to the group without MS. Conclusion: The frequency of MS and its individual components altered was high, especially among women.Introducción: El Síndrome Metabólico (SM) se caracteriza por un conjunto de factores que aumentan el riesgo de enfermedades cardiovasculares relacionadas con la obesidad central y la resistencia a la insulina. Las cifras de morbilidad y mortalidad y los costos socioeconómicos para los servicios de salud pública son alarmantes y su prevalencia varía según los criterios diagnósticos y públicos estudiados. La población mundial tiene una prevalencia del 25%, considerando los pacientes esquizofrénicos, la tasa de prevalencia media de SM encontrada es del 32,5%. La esquizofrenia es una psicosis crónica sin causa definida, una enfermedad multifactorial que aparece lenta o repentinamente y está relacionada con problemas de salud, como dificultad para el autocuidado, procesamiento del pensamiento, relaciones interpersonales, que favorece el aislamiento social y la dificultad en el proceso de rehabilitación. Objetivos: Determinar la prevalencia del síndrome metabólico (SM) en pacientes esquizofrénicos según los criterios diagnósticos internacionales de NCEP / ATP / III e IDF. Métodos: Estudio epidemiológico transversal y analítico. Se recogieron datos socioeconómicos, antropométricos, clínicos y bioquímicos. Para el análisis de los datos se utilizaron medidas de frecuencia absoluta, relativa y multivariante y se consideró un nivel de significancia del 5%. Resultados: La frecuencia de SM fue de 38,9 y 43,1%, NCEP / ATP / III e IDF respectivamente. Las mujeres tenían mayor presencia de EM y alteración de la circunferencia de la cintura que los hombres. El grupo con EM cambió con mayor frecuencia en términos de componentes individuales que cambiaron en comparación con el grupo sin EM. Conclusión: La frecuencia de la alteración de la EM y sus componentes individuales fue alta, especialmente entre las mujeres.Introdução: Síndrome Metabólica (SM) é caracterizada por um conjunto de fatores que aumentam risco de doenças cardiovasculares relacionada à obesidade central e resistência à insulina. Os números de morbimortalidade e custos socioeconômicos aos serviços públicos de saúde são alarmantes e sua prevalência varia conforme critério de diagnóstico e público estudado. A população mundial possui prevalência de 25%, considerando os pacientes esquizofrênicos, a taxa de prevalência média de SM encontrada é 32,5%. A esquizofrenia é uma psicose crônica sem causa definida, uma doença multifatorial que aparece de forma lenta ou súbita e está relacionada a problemas de saúde, como dificuldade com autocuidado, processamento do pensamento, relações interpessoais, o que favorece isolamento social e dificulta o processo de reabilitação. Objetivos: Determinar a prevalência da síndrome metabólica (SM) em pacientes esquizofrênicos de acordo com os critérios internacionais de diagnóstico da NCEP/ATP/III e IDF. Métodos: Estudo epidemiológico de caráter transversal e analítico. Foram coletados dados socioeconômicos, antropométricos, clínicos e bioquímicos. Para análise dos dados foram utilizadas medidas de frequência absolutas, relativas e multivariadas, e considerado o nível de significância de 5%. Resultados: A frequência da SM foi de 38,9 e 43,1%, NCEP/ATP/III e IDF respectivamente. As mulheres apresentaram maior presença da SM e alteração da circunferência da cintura que os homens. O grupo com SM demonstrou maior frequência quanto aos componentes individuais alterados em relação ao grupo sem SM. Conclusão: A frequência da SM e dos seus componentes individuais alterados foi alta, principalmente entre as mulheres.Research, Society and Development2021-08-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1890410.33448/rsd-v10i11.18904Research, Society and Development; Vol. 10 No. 11; e93101118904Research, Society and Development; Vol. 10 Núm. 11; e93101118904Research, Society and Development; v. 10 n. 11; e931011189042525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/18904/17294Copyright (c) 2021 Juscelino de Souza Borges Neto; Juliana Mara Flores Bicalho; Thais Marques da Silva; Mariana Sousa Vieira; Wendell Costa Bila; Pedro Henrique Batista de Freitas; Richardson Miranda Machado; Paulo Afonso Granjeirohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBorges Neto, Juscelino de Souza Bicalho, Juliana Mara Flores Silva, Thais Marques daVieira, Mariana SousaBila, Wendell CostaFreitas, Pedro Henrique Batista deMachado, Richardson MirandaGranjeiro, Paulo Afonso 2021-10-23T19:01:11Zoai:ojs.pkp.sfu.ca:article/18904Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:55.555451Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Frequency of metabolic syndrome in schizophrenic patients Frecuencia de síndrome metabólico en pacientes esquizofrénicos Frequência da síndrome metabólica em pacientes esquizofrênicos |
title |
Frequency of metabolic syndrome in schizophrenic patients |
spellingShingle |
Frequency of metabolic syndrome in schizophrenic patients Frequency of metabolic syndrome in schizophrenic patients Borges Neto, Juscelino de Souza Metabolyc Syndrome Heart Disease Risk Factors Schizophrenia. Síndrome Metabólico Factores de Riesgo de Enfermedad Cardiaca Esquizofrenia. Síndrome Metabólica Fatores de Risco para Doenças Cardiovasculares Esquizofrenia. Borges Neto, Juscelino de Souza Metabolyc Syndrome Heart Disease Risk Factors Schizophrenia. Síndrome Metabólico Factores de Riesgo de Enfermedad Cardiaca Esquizofrenia. Síndrome Metabólica Fatores de Risco para Doenças Cardiovasculares Esquizofrenia. |
title_short |
Frequency of metabolic syndrome in schizophrenic patients |
title_full |
Frequency of metabolic syndrome in schizophrenic patients |
title_fullStr |
Frequency of metabolic syndrome in schizophrenic patients Frequency of metabolic syndrome in schizophrenic patients |
title_full_unstemmed |
Frequency of metabolic syndrome in schizophrenic patients Frequency of metabolic syndrome in schizophrenic patients |
title_sort |
Frequency of metabolic syndrome in schizophrenic patients |
author |
Borges Neto, Juscelino de Souza |
author_facet |
Borges Neto, Juscelino de Souza Borges Neto, Juscelino de Souza Bicalho, Juliana Mara Flores Silva, Thais Marques da Vieira, Mariana Sousa Bila, Wendell Costa Freitas, Pedro Henrique Batista de Machado, Richardson Miranda Granjeiro, Paulo Afonso Bicalho, Juliana Mara Flores Silva, Thais Marques da Vieira, Mariana Sousa Bila, Wendell Costa Freitas, Pedro Henrique Batista de Machado, Richardson Miranda Granjeiro, Paulo Afonso |
author_role |
author |
author2 |
Bicalho, Juliana Mara Flores Silva, Thais Marques da Vieira, Mariana Sousa Bila, Wendell Costa Freitas, Pedro Henrique Batista de Machado, Richardson Miranda Granjeiro, Paulo Afonso |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Borges Neto, Juscelino de Souza Bicalho, Juliana Mara Flores Silva, Thais Marques da Vieira, Mariana Sousa Bila, Wendell Costa Freitas, Pedro Henrique Batista de Machado, Richardson Miranda Granjeiro, Paulo Afonso |
dc.subject.por.fl_str_mv |
Metabolyc Syndrome Heart Disease Risk Factors Schizophrenia. Síndrome Metabólico Factores de Riesgo de Enfermedad Cardiaca Esquizofrenia. Síndrome Metabólica Fatores de Risco para Doenças Cardiovasculares Esquizofrenia. |
topic |
Metabolyc Syndrome Heart Disease Risk Factors Schizophrenia. Síndrome Metabólico Factores de Riesgo de Enfermedad Cardiaca Esquizofrenia. Síndrome Metabólica Fatores de Risco para Doenças Cardiovasculares Esquizofrenia. |
description |
Introduction: Metabolic Syndrome (MS) is characterized by a set of factors that increase the risk of cardiovascular diseases related to central obesity and insulin resistance. The numbers of morbidity and mortality and socioeconomic costs to public health services are alarming and their prevalence varies according to the diagnostic criteria and the population studied. The world population has a prevalence of 25%, considering schizophrenic patients, the mean MS prevalence rate found is 32.5%. Schizophrenia is a chronic psychosis without a defined cause, a multifactorial disease that appears slowly or suddenly and is related to health problems, such as difficulty with self-care, thought processing, interpersonal relationships, which favors social isolation and difficulty in the rehabilitation process. Objectives: To determine the prevalence of metabolic syndrome (MS) in schizophrenic patients according to the international diagnostic criteria of NCEP / ATP / III and IDF. Methods: Cross-sectional and analytical epidemiological study. Socioeconomic, anthropometric, clinical and biochemical data were collected. For data analysis, absolute, relative and multivariate frequency measures were used, and a significance level of 5% was considered. Results: The frequency of MS was 38.9 and 43.1%, NCEP / ATP / III and IDF respectively. Women had a greater presence of MS and altered waist circumference than men. The group with MS changed more frequently in terms of individual components changed compared to the group without MS. Conclusion: The frequency of MS and its individual components altered was high, especially among women. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-24 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18904 10.33448/rsd-v10i11.18904 |
url |
https://rsdjournal.org/index.php/rsd/article/view/18904 |
identifier_str_mv |
10.33448/rsd-v10i11.18904 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18904/17294 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 11; e93101118904 Research, Society and Development; Vol. 10 Núm. 11; e93101118904 Research, Society and Development; v. 10 n. 11; e93101118904 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1822178510796488704 |
dc.identifier.doi.none.fl_str_mv |
10.33448/rsd-v10i11.18904 |